Pharma group Hikma looks to take advantage as Novo Nordisk’s Wegovy and Ozempic start to go off patent next year ...

he criticised people for using Ozempic for weight loss, leading to shortages for diabetic patients who rely on the drug.

Weight loss drugs like Ozempic, while transformative in combating obesity, have been linked to irreversible vision impairment ...

Q4 2024 Earnings Call Transcript March 3, 2025 Fractyl Health, Inc. Common Stock misses on earnings expectations. Reported EPS is $-0.52 EPS, expectations were $-0.44. Operator: Good afternoon, and ...

I was shocked to read that Valerie Arkoosh, Pennsylvania’s secretary of human services, didn’t anticipate the cost of ...

In a reel, which has been viewed 600,000 times, Shaun Christopher explains that eating apples 'naturally boosts GLP-1, the ...

Hims & Hers generated $1.5 billion in revenue in 2024, reflecting a 69% year-over-year increase. See why I rate HIMS stock a ...

Novo Nordisk says many Australians would be willing to pay the out-of-pocket costs for its blockbuster medicines, which can ...

While the transformation has contributed to Amy’s regained self-esteem, she has also been sharing her experience to help ...

Women who have quickly lost weight say strangers are now more likely to smile at them or strike up a conversation.

Glp-1s cover a variety of drugs that are commonly used for weight loss, such as Ozempic, Wegovy and Mounjaro. And West Virginians used them at the highest rate ...

Hims & Hers Health will shut down Apostrophe, its personalized acne treatments dermatology business, the company said on Friday. Apostrophe is being shut down to “simplify its (company’s) dermatology ...